PTAB grants inter partes review of China’s firm’s Alzheimer’s patent
22-07-2021
Jonathan Weiss / Shutterstock.com
Avid Radiopharmaceuticals, a subsidiary of Eli Lilly, has taken the Alzheimer's Institute of America (AIA) to court over its “malicious” prosecution of a patent infringement case.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Eli Lilly, Avid Radiopharmaceuticals, Alzheimer's Institute of America, malicious patent infringement, Alzheimer’s, Imperial College
